Jones Research analyst Catherine Novack discusses Capricor's regulatory roller coaster, RNA editing, and more

She gives a scenario analysis in the event that FDA asked Capricor for more data rather than approving the therapy by its August 31st decision date. Plus, commentary on ProQR, Korro Bio, Wave, Crinetics, Dyne, Rezolute, Larimar, and Aldeyra.

Episode metadata supplied by the publisher feed · Published Jun 27, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Jones Research analyst Catherine Novack discusses Capricor's regulatory roller coaster, RNA editing, and more

0:00 13:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BiotechTV - News?

This episode is 13 minutes long.

When was this BiotechTV - News episode published?

This episode was published on June 27, 2025.

Can I download this BiotechTV - News episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!